ABSTRACT
This study was designed to explore the cyproterone acetate (CPA)-induced andrological hypofunction and its correction by oral administration of lycopene. In this concern, spermatogenic, biochemical, histological and genomic profiles were studied. Cyproterone acetate administration for 1 month helped to develop infertile model rats. A significant recovery was noted in sperm motility, sperm count, sperm viability, hypo-osmotic swelling tail-coiled spermatozoa; activities of testicular ∆5 , 3ß-hydroxysteroid dehydrogenase (HSD), 17ß-HSD, catalase (CAT) and superoxide dismutase (SOD); and levels of conjugated diene (CD), malondialdehyde (MDA), testicular cholesterol and serum testosterone after the administration of lycopene at 1.5 mg/0.5 ml Tween-80/100 g body weight/day for last 1 month to infertile model rats. Simultaneously, qRT-PCR study of Bax, Bcl-2, caspase-3, ∆5 , 3ß-HSD and 17ß-HSD genes in testicular tissue showed a significant rectification towards the control in CPA-pre-treated cum CPA-lycopene-cotreated rats. Side-by-side histological and histometric studies showed a significant correction in qualitative analysis of spermatogenesis and seminiferous tubular diameter (STD) in CPA-pre-treated cum CPA-lycopene-cotreated rats. Lycopene showed outstanding efficacy in the management of CPA-induced testicular hypofunction with special reference to correction in oxidative stress-induced testicular apoptosis at genomic level.
Subject(s)
Carotenoids/pharmacology , Cyproterone Acetate/pharmacology , Dietary Supplements , Oxidative Stress/drug effects , Spermatozoa/drug effects , Testis/drug effects , Animals , Catalase/metabolism , Cell Survival/drug effects , Genomics , Lycopene , Male , Malondialdehyde/metabolism , Rats , Sperm Count , Sperm Motility/drug effects , Spermatogenesis/drug effects , Spermatozoa/cytology , Spermatozoa/metabolism , Superoxide Dismutase/metabolismABSTRACT
This study was designed to focus the genetic regulation of diabetes-induced testicular hypofunction and its amelioration by ethyl acetate fraction of seed of Eugenia jambolana. In this regard, we have assessed relevant biosensors such as biochemical, spermiological, histological and gene expression of antioxidant enzymes, germ cell apoptosis and androgenic key enzymes along with in situ end labelling and DNA fragmentation study. After 60 days administration of said fraction, significant recovery in the glycated haemoglobin, serum testosterone, sperm viability, hypo-osmotic swelling and nuclear chromatin decondensation were noted in fraction-treated diabetic group in comparison with diabetic control. Besides this, a significant recovery in the expression of Bax, Bcl-2, caspase-9, caspase-3, catalase, peroxidase, ∆(5) , 3ß-hydroxy steroid dehydrogenase and 17ß-hydroxy steroid dehydrogenase genes was noted towards the control in ethyl acetate fraction-treated group. Testicular histology focused a significant recovery in the number of different generation of germ cells at stage VII of spermatogenesis in fraction-treated group. In situ end labelling and DNA fragmentation study of testicular tissues also showed a significant recovery in fraction-treated group towards the control. These findings indicate that the ethyl acetate fraction showed outstanding antiapoptotic activity by neutralising oxidative stress as well as by the improvement in glycaemic sensors.